Juliet C. Gray

Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function

Sarah L. Buchan, Lang Dou, Marcus Remer et al. · Immunity · 2018 · 153 citations · Full text

Life Sciences, Immunology, Oncology +14

Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulation

Ruth R. French, Vadim Y. Taraban, Graham Crowther et al. · Blood · 2007 · 117 citations · Full text

Life Sciences, Immunology, Oncology +16

Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy

Judith Wienke, Lindy L. Visser, Waleed M. Kholosy et al. · Cancer Cell · 2024 · 101 citations · Full text

Life Sciences, Immunology, Oncology +17

Mutations in the transcriptional repressor REST predispose to Wilms tumor

Shazia Mahamdallie, Sandra Hanks, Kristen L. Karlin et al. · Nature Genetics · 2015 · 83 citations

Life Sciences, Genetics, Molecular Biology +14

ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients

Andrew D.J. Pearson, Claudia Rössig, Giovanni Lesa et al. · European Journal of Cancer · 2020 · 68 citations · Full text

Medicine, Oncology, Pediatrics +17